2018
DOI: 10.1101/478479
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Lin28B is involved in curcumin-reversed paclitaxel chemoresistance and associated with poor prognosis in hepatocellular carcinoma

Abstract: statement upregulation of Lin28B not only confers poor prognosis in HCC patients but also increases chemoresistance in HCC cells. Thus, Lin28B may serve as a predictive biomarker for use to reverse chemoresistance in clinical practice. AbstractChemoresistance remains a big challenge in hepatocellular carcinoma (HCC) treatment. Several studies indicated that RNA-binding protein Lin28B serves an oncogenic role in HCC, but its activity in HCC chemotherapy has never been assessed. In this study, we found that over… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 49 publications
0
7
0
Order By: Relevance
“…LIN28B serves as a key driver gene in HBx-induced hepatocarcinogenesis [21]. LIN28B is overexpressed in HCC [10,18,22] and its expression promotes transformation and invasion of HCC [18] while the suppression of LIN28B expression inhibits HCC cell proliferation and metastasis [23]. Higher expression of LIN28B is associated with shorter overall survival in HCC patients [22].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…LIN28B serves as a key driver gene in HBx-induced hepatocarcinogenesis [21]. LIN28B is overexpressed in HCC [10,18,22] and its expression promotes transformation and invasion of HCC [18] while the suppression of LIN28B expression inhibits HCC cell proliferation and metastasis [23]. Higher expression of LIN28B is associated with shorter overall survival in HCC patients [22].…”
Section: Introductionmentioning
confidence: 99%
“…LIN28B is overexpressed in HCC [10,18,22] and its expression promotes transformation and invasion of HCC [18] while the suppression of LIN28B expression inhibits HCC cell proliferation and metastasis [23]. Higher expression of LIN28B is associated with shorter overall survival in HCC patients [22]. LIN28B in the peripheral blood mononuclear cells is shown to be an oncofetal circulating cancer stem cell-like marker associated with recurrence of HCC [24].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In PDAC patients, high LIN28B expression was significantly correlated with high levels of lymphatic metastasis, distant metastasis and a poor prognosis. In addition, patients with increased LIN28B had markedly reduced overall survival compared to those with low LIN28B in HCC [62] and oral squamous cell carcinoma (OSCC) [63]. Thus, LIN28B is highly expressed in CRC and plays an important role in its pathogenesis, indicating that it is suitable as a target gene for CRC prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…LIN28B is highly expressed in liver cells and is related to the level of alpha-fetoprotein, which promotes the tumorigenesis and progression of HCC. The overall survival rate of HCC patients with high LIN28B expression in signi cantly shortened, which is related to the multidrug resistance of HCC [41] . SMG5 is highly expressed in malignant tumors, especially prostate cancer and it is a potential molecular marker for the early diagnosis of cancers [42] .…”
Section: Discussionmentioning
confidence: 99%